234 related articles for article (PubMed ID: 10934603)
41. Risedronate: clinical usage.
Chapurlat RD; Delmas PD
Int J Clin Pract; 2001 May; 55(4):275-8. PubMed ID: 11406915
[TBL] [Abstract][Full Text] [Related]
42. From bathtub ring to osteoporosis: a clinical review of the bisphosphonates.
Licata AA
Cleve Clin J Med; 1993; 60(4):284-90. PubMed ID: 8339454
[TBL] [Abstract][Full Text] [Related]
43. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
44. What is new in the treatment of steroid-induced osteoporosis?
Liu RH; Werth VP
Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
[TBL] [Abstract][Full Text] [Related]
45. Management of Paget's disease of bone.
Langston AL; Ralston SH
Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
[TBL] [Abstract][Full Text] [Related]
46. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
[TBL] [Abstract][Full Text] [Related]
47. Bisphosphonates in orthopaedic surgery.
Morris CD; Einhorn TA
J Bone Joint Surg Am; 2005 Jul; 87(7):1609-18. PubMed ID: 15995133
[TBL] [Abstract][Full Text] [Related]
48. Bisphosphonates in the treatment of metabolic bone diseases.
Rodan GA; Balena R
Ann Med; 1993 Aug; 25(4):373-8. PubMed ID: 8217103
[TBL] [Abstract][Full Text] [Related]
49. [The use of bisphosphonates for treating pathological states in orthopedics].
Białecki P; Bohatyrewicz A; Machoy-Mokrzyńska A; Białecka M
Chir Narzadow Ruchu Ortop Pol; 2008; 73(4):266-73. PubMed ID: 18847019
[TBL] [Abstract][Full Text] [Related]
50. [Pharmacotherapy of osteoporosis: prospects of bisphosphonates].
Nasonov EL; Skripnikova IA; Benevolenskaia LI; Nasonova VA
Klin Med (Mosk); 1996; 74(9):16-22. PubMed ID: 9121080
[No Abstract] [Full Text] [Related]
51. Bisphosphonates in bone diseases other than osteoporosis.
Orcel P; Beaudreuil J
Joint Bone Spine; 2002 Jan; 69(1):19-27. PubMed ID: 11858352
[TBL] [Abstract][Full Text] [Related]
52. Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases.
Rosen CJ; Kessenich CR
Drugs; 1996 Apr; 51(4):537-51. PubMed ID: 8706593
[TBL] [Abstract][Full Text] [Related]
53. How do bone resorption inhibitors increase bone mineral density?
Boivin G; Meunier PJ
Rev Rhum Engl Ed; 1999 Nov; 66(11):534-7. PubMed ID: 10591113
[No Abstract] [Full Text] [Related]
54. Diphosphonates: aimed in a chemical sense.
Lancet; 1981 Dec; 2(8259):1326-8. PubMed ID: 6118722
[No Abstract] [Full Text] [Related]
55. Effects of sodium fluoride on bone. Application to otosclerosis and other decalcifying bone diseases.
Shambaugh GE; Petrovic A
JAMA; 1968 Jun; 204(11):969-73. PubMed ID: 5694686
[No Abstract] [Full Text] [Related]
56. Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update.
Fleisch H
Horm Metab Res; 1997 Mar; 29(3):145-50. PubMed ID: 9137986
[TBL] [Abstract][Full Text] [Related]
57. The role of bisphosphonates in diseases of childhood.
Srivastava T; Alon US
Eur J Pediatr; 2003 Nov; 162(11):735-51. PubMed ID: 14523647
[TBL] [Abstract][Full Text] [Related]
58. Bisphosphonates in osteoporosis: an introduction.
Fleisch H
Osteoporos Int; 1993; 3 Suppl 3():S3-5. PubMed ID: 8298201
[TBL] [Abstract][Full Text] [Related]
59. Bisphosphonates: pharmacology and effects on the growing skeleton.
Papapoulos SE
Acta Univ Carol Med (Praha); 1994; 40(1-4):29-32. PubMed ID: 9355668
[No Abstract] [Full Text] [Related]
60. The effects of fluoride therapy on metabolic bone disease. A histologic study.
Baylink DJ; Bernstein DS
Clin Orthop Relat Res; 1967; 55():51-85. PubMed ID: 6079753
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
